Potential of Therapeutic Phages to Combat MDR ESKAPE Pathogens in Developing Nations

Dr. Lilian Musila, U.S. Army Medical Research Directorate-Africa, Kenya, will join the Phage Therapy Congress to present her latest research on “Potential of Therapeutic Phages to Combat MDR ESKAPE Pathogens in Developing Nations”.

Dr. Musila is a biomedical research scientist with a Ph.D. in Molecular Parasitology from the University of Pennsylvania, Philadelphia, PA, USA, and a B.Sc. in Microbiology from the University of Massachusetts, Amherst, MA, USA. She has decades of international research,  academic, and teaching experience in microbiology, parasitology, human genetics, cancer, virology, developmental, and molecular biology. Dr. Musila has worked for the past fourteen years at Kenya Medical Research Institute, Nairobi, Kenya, for the Walter Reed Project. Her work has focused on infectious disease surveillance and research on viral and bacterial pathogens. As the head of the Antimicrobial resistance program she focusses on antimicrobial resistance surveillance of World Health Organization priority ESKAPE pathogens to track antibiotic resistance trends and define their distribution across the country and the genes responsible for antibiotic resistance and virulence. She is devoted to providing innovative interventions and diagnostics to the challenges of infectious diseases and antimicrobial resistance.

Join the congress to benefit from the experience of professionals like Dr. Musila.

Targeting Phage Therapy 2023
6th World Conference
June 1-2, 2023 – Paris, France